Cogent Biosciences, Inc., a biotechnology company focused on developing precision therapies for genetically defined diseases, announced the pricing of an underwritten public offering of 10,256,411 shares of its common stock, offered at a public offering price of $9.75 per share.
December 1, 2020
· 5 min read
